Turkish Journal of Nephrology
Review

Current Status of Renal Replacement Therapy in Turkey: A Summary of Turkish Society of Nephrology 2009 Annual Registry Report

1.

Akdeniz Üniversitesi, Akdeniz Tıp Fakültesi, İç hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, Antalya, Türkiye

2.

İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, İç hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye

Turkish J Nephrol 2011; 20: 1-6
DOI: 10.5262/tndt.2011.1001.01
Read: 462 Downloads: 227 Published: 06 February 2019

Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on annual basis. Registry reports are printed every year as a booklet and this is the 20th year of registry reports. The registry is in close collaboration with international registries.

In this paper data from the 2009 registry report are summarized, additionally yearly trends in the management of end stage renal disease are also provided

The number of patients on renal replacement therapy is rapidly increasing, at the end of 2009, 59443 patients were on renal replacement therapy. The prevalence and incidence of end stage renal disease was 819 and 197 per million population respectively. Diabetes was the most important cause of end stage renal disease. Hemodialysis (78.5%) was the most common type of treatment modality, followed by transplantation (12.4%) and peritoneal dialysis (9.1%)

End stage renal disease is a very important and growing health problem for our country. Renal registry is a leading tool for providing current and sound data on this public health problem.

Files
EISSN 2667-4440